(Q40563622)

English

Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma

scientific article published on March 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma (English)

1 reference

Europe PubMed Central

21 September 2017

author name string

Jantunen E

1

1 reference

Europe PubMed Central

21 September 2017

Putkonen M

2

1 reference

Europe PubMed Central

21 September 2017

Nousiainen T

3

1 reference

Europe PubMed Central

21 September 2017

Pelliniemi TT

4

1 reference

Europe PubMed Central

21 September 2017

Mahlamäki E

5

1 reference

Europe PubMed Central

21 September 2017

Remes K

6

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

1 March 2003

1 reference

Europe PubMed Central

21 September 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

21 September 2017

31

1 reference

Europe PubMed Central

21 September 2017

347-351

1 reference

Europe PubMed Central

21 September 2017

5

1 reference

Europe PubMed Central

21 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703840

0 references

Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703840

21 January 2018

Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703840

21 January 2018

Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703840

21 January 2018

Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703840

21 January 2018

Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703840

21 January 2018

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703840

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic stem cell transplantation activity in Europe 1999

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703840

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703840

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703840

7 January 2021

based on heuristic

inferred from DOI database lookup

CD34 counts to predict the adequate collection of peripheral blood progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703840

7 January 2021

based on heuristic

inferred from DOI database lookup

Daily measurements of blood CD34+ cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703840

7 January 2021

based on heuristic

inferred from DOI database lookup

Stem cell mobilisation in lymphoproliferative diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703840

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703840

7 January 2021

based on heuristic

inferred from DOI database lookup

G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703840

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703840

1 reference

Europe PubMed Central

21 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40563622&oldid=1900590511"